Literature DB >> 32028011

Soluble FcεRI, IgE, and tryptase as potential biomarkers of rapid desensitizations for platin IgE sensitized cancer patients.

Sherezade Moñino-Romero1, Leticia de Las Vecillas2, Leila A Alenazy3, Marina Labella4, Zsolt Szépfalusi5, Edda Fiebiger6, Mariana C Castells4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32028011      PMCID: PMC9012077          DOI: 10.1016/j.jaip.2020.01.047

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  9 in total

1.  Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes.

Authors:  Ghislaine Annie C Isabwe; Marlene Garcia Neuer; Leticia de Las Vecillas Sanchez; Donna-Marie Lynch; Kathleen Marquis; Mariana Castells
Journal:  J Allergy Clin Immunol       Date:  2018-03-05       Impact factor: 10.793

2.  The soluble isoform of human FcɛRI is an endogenous inhibitor of IgE-mediated mast cell responses.

Authors:  S Moñino-Romero; L Erkert; K Schmidthaler; S C Diesner; B F Sallis; L Pennington; T Jardetzky; H C Oettgen; B Bohle; E Fiebiger; Z Szépfalusi
Journal:  Allergy       Date:  2018-11-20       Impact factor: 13.146

3.  Nanoallergen platform for detection of platin drug allergies.

Authors:  Peter E Deak; Baksun Kim; Ather Adnan; Marina Labella; Leticia De Las Vecillas; Mariana Castells; Basar Bilgicer
Journal:  J Allergy Clin Immunol       Date:  2019-01-23       Impact factor: 10.793

4.  Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer.

Authors:  Gary Altwerger; Esther B Florsheim; Gulden Menderes; Jonathan Black; Carlton Schwab; Gregory M Gressel; Wendelin K Nelson; Nina Carusillo; Terri Passante; Gloria Huang; Babak Litkouhi; Masoud Azodi; Dan-Arin Silasi; Alessandro Santin; Peter E Schwartz; Elena S Ratner
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-25       Impact factor: 4.553

Review 5.  Platinum Chemotherapy Hypersensitivity: Prevalence and Management.

Authors:  Iris M Otani; Johnson Wong; Aleena Banerji
Journal:  Immunol Allergy Clin North Am       Date:  2017-08-19       Impact factor: 3.479

Review 6.  Drug Hypersensitivity and Desensitizations: Mechanisms and New Approaches.

Authors:  Leticia de Las Vecillas Sánchez; Leila A Alenazy; Marlene Garcia-Neuer; Mariana C Castells
Journal:  Int J Mol Sci       Date:  2017-06-20       Impact factor: 5.923

Review 7.  Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers.

Authors:  Teodorikez Wilfox Jimenez-Rodriguez; Marlene Garcia-Neuer; Leila A Alenazy; Mariana Castells
Journal:  J Asthma Allergy       Date:  2018-06-20

8.  Soluble FcɛRI: A biomarker for IgE-mediated diseases.

Authors:  Sherezade Moñino-Romero; Willem S Lexmond; Josef Singer; Christina Bannert; Abena S Amoah; Maria Yazdanbakhsh; Daniel A Boakye; Erika Jensen-Jarolim; Edda Fiebiger; Zsolt Szépfalusi
Journal:  Allergy       Date:  2019-03-11       Impact factor: 13.146

Review 9.  Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations.

Authors:  Mariana Castells
Journal:  Front Immunol       Date:  2017-11-08       Impact factor: 7.561

  9 in total
  5 in total

Review 1.  Advances and highlights in biomarkers of allergic diseases.

Authors:  Ismail Ogulur; Yagiz Pat; Ozge Ardicli; Elena Barletta; Lacin Cevhertas; Ruben Fernandez-Santamaria; Mengting Huang; Manal Bel Imam; Jana Koch; Siyuan Ma; Debbie J Maurer; Yasutaka Mitamura; Yaqi Peng; Urszula Radzikowska; Arturo O Rinaldi; Juan Rodriguez-Coira; Pattraporn Satitsuksanoa; Stephan R Schneider; Alexandra Wallimann; Damir Zhakparov; Reihane Ziadlou; Marie-Charlotte Brüggen; Willem van de Veen; Milena Sokolowska; Katja Baerenfaller; Luo Zhang; Mubeccel Akdis; Cezmi A Akdis
Journal:  Allergy       Date:  2021-09-27       Impact factor: 14.710

2.  The relationship between released soluble FceRI-alpha and its cell surface density on human basophils.

Authors:  Donald MacGlashan
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

3.  Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions.

Authors:  Begum Gorgulu Akin; Merve Erkoc; Elif Tugce Korkmaz; Betul Ozdel Ozturk; Sevgi Colak; Funda Seher Ozalp Ates; Sevim Bavbek
Journal:  World Allergy Organ J       Date:  2021-12-20       Impact factor: 4.084

Review 4.  Drug hypersensitivity, in vitro tools, biomarkers, and burden with COVID-19 vaccines.

Authors:  Francisca Palomares; Juan L Paris; Marina Labella; Inmaculada Doña; Cristobalina Mayorga; María José Torres
Journal:  Allergy       Date:  2022-08-01       Impact factor: 14.710

Review 5.  Hypersensitivity Reactions to Platinum Agents and Taxanes.

Authors:  Lulu R Tsao; Fernanda D Young; Iris M Otani; Mariana C Castells
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-02       Impact factor: 10.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.